Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Net Margin (2021 - 2025)

Historic Net Margin for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to 161.24%.

  • Molecular Partners Ag's Net Margin rose 15036700.0% to 161.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 226.64%, marking a year-over-year increase of 10623302100.0%. This contributed to the annual value of 1080.86% for FY2024, which is 8854846334300.0% up from last year.
  • Per Molecular Partners Ag's latest filing, its Net Margin stood at 161.24% for Q3 2025, which was up 15036700.0% from 1286.17% recorded in Q1 2025.
  • Over the past 5 years, Molecular Partners Ag's Net Margin peaked at 13822.69% during Q4 2023, and registered a low of 579182050.15% during Q1 2024.
  • Its 5-year average for Net Margin is 59659214.49%, with a median of 406.33% in 2021.
  • Its Net Margin has fluctuated over the past 5 years, first plummeted by 2000000000bps in 2023, then soared by 2000000000bps in 2025.
  • Molecular Partners Ag's Net Margin (Quarter) stood at 599.86% in 2021, then soared by 110bps to 62.15% in 2022, then skyrocketed by 22141bps to 13822.69% in 2023, then plummeted by -99bps to 144.52% in 2024, then crashed by -212bps to 161.24% in 2025.
  • Its Net Margin stands at 161.24% for Q3 2025, versus 1286.17% for Q1 2025 and 144.52% for Q4 2024.